Literature DB >> 23986197

Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.

Hector Rasgado-Flores1, Vamsi Krishna Mandava, Homayoun Siman, Willy Van Driessche, Joseph M Pilewski, Scott H Randell, Robert J Bridges.   

Abstract

Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was <2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.

Entities:  

Keywords:  Na+ transport; amiloride; cystic fibrosis; human bronchial epithelial cells; hyperosmotic saline

Mesh:

Substances:

Year:  2013        PMID: 23986197      PMCID: PMC3882386          DOI: 10.1152/ajpcell.00166.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  41 in total

Review 1.  Exercise-induced bronchoconstriction in the 21st century.

Authors:  Sandra D Anderson
Journal:  J Am Osteopath Assoc       Date:  2011-11

2.  Effects of hyperosmotic stress on cultured airway epithelial cells.

Authors:  Harriet Nilsson; Anca Dragomir; Anders Ahlander; Marie Johannesson; Godfried M Roomans
Journal:  Cell Tissue Res       Date:  2007-09-04       Impact factor: 5.249

3.  Intracellular sodium regulates proteolytic activation of the epithelial sodium channel.

Authors:  Kristin K Knight; Danielle M Wentzlaff; Peter M Snyder
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

Review 4.  Update in cystic fibrosis 2012.

Authors:  Christopher H Goss; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

5.  Use of primary cultures of human bronchial epithelial cells isolated from cystic fibrosis patients for the pre-clinical testing of CFTR modulators.

Authors:  Timothy Neuberger; Bill Burton; Heather Clark; Fredrick Van Goor
Journal:  Methods Mol Biol       Date:  2011

Review 6.  Mechano-sensitivity of ENaC: may the (shear) force be with you.

Authors:  Martin Fronius; Wolfgang G Clauss
Journal:  Pflugers Arch       Date:  2007-09-15       Impact factor: 3.657

7.  Inhaled mannitol improves lung function in cystic fibrosis.

Authors:  Anna Jaques; Evangelia Daviskas; James A Turton; Karen McKay; Peter Cooper; Robert G Stirling; Colin F Robertson; Peter T P Bye; Peter N LeSouëf; Bruce Shadbolt; Sandra D Anderson; Brett Charlton
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

Review 8.  Nebulised hypertonic saline for cystic fibrosis.

Authors:  Peter Wark; Vanessa M McDonald
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

9.  Understanding the cellular mechanism for inhaled hyperosmotic saline therapy for patients with cystic fibrosis. Focus on "Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors".

Authors:  Carole M Liedtke
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

10.  Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis.

Authors:  Mike M Myerburg; Erin E McKenna; Cliff J Luke; Raymond A Frizzell; Thomas R Kleyman; Joseph M Pilewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-29       Impact factor: 5.464

View more
  6 in total

1.  Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.

Authors:  Lauren P Lashua; Jeffrey A Melvin; Berthony Deslouches; Joseph M Pilewski; Ronald C Montelaro; Jennifer M Bomberger
Journal:  J Antimicrob Chemother       Date:  2016-05-26       Impact factor: 5.790

2.  Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis.

Authors:  Carla Cristina Souza Gomez; Paloma Lopes Francisco Parazzi; Karl Jan Clinckspoor; Renan Marrichi Mauch; Francisco Benedito Teixeira Pessine; Carlos Emilio Levy; Andressa Oliveira Peixoto; Maria Ângela Gonçalves Oliveira Ribeiro; Antônio Fernando Ribeiro; Douglas Conrad; Paul Marquis Quinton; Fernando Augusto Lima Marson; José Dirceu Ribeiro
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

3.  The in vitro effect of nebulised hypertonic saline on human bronchial epithelium.

Authors:  Jennifer L Goralski; Dan Wu; William R Thelin; Richard C Boucher; Brian Button
Journal:  Eur Respir J       Date:  2018-05-17       Impact factor: 16.671

4.  Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells.

Authors:  Anna C Zemke; Sruti Shiva; Jane L Burns; Samuel M Moskowitz; Joseph M Pilewski; Mark T Gladwin; Jennifer M Bomberger
Journal:  Free Radic Biol Med       Date:  2014-09-16       Impact factor: 7.376

Review 5.  Osmolytes and ion transport modulators: new strategies for airway surface rehydration.

Authors:  Jennifer L Goralski; Richard C Boucher; Brian Button
Journal:  Curr Opin Pharmacol       Date:  2010-05-01       Impact factor: 5.547

6.  CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation.

Authors:  Xia Hou; Qingtian Wu; Carthic Rajagopalan; Chunbing Zhang; Mohamad Bouhamdan; Hongguang Wei; Xuequn Chen; Khalequz Zaman; Chunying Li; Xiaonan Sun; Song Chen; Raymond A Frizzell; Fei Sun
Journal:  FASEB J       Date:  2019-08-26       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.